
PAT-048
CAS No. 1359983-15-5
PAT-048( PAT 048 | PAT048 )
Catalog No. M11477 CAS No. 1359983-15-5
PAT-048 (PAT048) is a?potent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 963 | Get Quote |
![]() ![]() |
50MG | 1962 | Get Quote |
![]() ![]() |
100MG | 2520 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePAT-048
-
NoteResearch use only, not for human use.
-
Brief DescriptionPAT-048 (PAT048) is a?potent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.
-
DescriptionPAT-048 (PAT048) is a?potent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX; exhibits good potency for inhibition of lysoPLD activity with IC50 of 8.9 nM and 22 nM in human blood and mouse plasma, respectively; decreases ATX activity systemically and in the lung, without effect on pulmonary LPA or fibrosis in bleomycin-challenged mice.
-
In Vitro——
-
In Vivo——
-
SynonymsPAT 048 | PAT048
-
PathwayWnt/Notch/Hedgehog
-
TargetAutotaxin
-
RecptorAutotaxin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1359983-15-5
-
Formula Weight461.912
-
Molecular FormulaC22H18ClF2N3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCN1N=CC(N2C(C(F)=C(Cl)C=C3)=C3C(SC4=CC=CC(C(O)=O)=C4F)=C2C)=C1
-
Chemical Name3-((6-chloro-7-fluoro-2-methyl-1-(1-propyl-1H-pyrazol-4-yl)-1H-indol-3-yl)thio)-2-fluorobenzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Black KE, et al. FASEB J. 2016 Jun;30(6):2435-50.
2. Castelino FV, et al. Arthritis Rheumatol. 2016 Dec;68(12):2964-2974.
3. Bain G, et al. J Pharmacol Exp Ther. 2017 Jan;360(1):1-13.
molnova catalog



related products
-
PAT-505
PAT-505 (PAT 505, PAT505) is a potent, selective, noncompetitive, and orally active autotaxin inhibitor with IC50 of 2.0 nM against the lysoPLD activity of human ATX.
-
GLPG-1690
GLPG-1690 (Ziritaxestat, GLPG1690) is a first-in-class, potent, competitive autotaxin inhibitor with Ki/IC50 of 15 nM/131 nM.
-
PAT-048
PAT-048 (PAT048) is a?potent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.